New hope for myeloma patients who relapse after CAR-T
Disease control
Recruiting now
This study is testing whether a combination of three drugs (elotuzumab, iberdomide, and dexamethasone) can help control multiple myeloma in patients whose cancer has returned or stopped responding to many treatments, including a recent CAR-T cell therapy. The goal is to see if th…
Phase: PHASE1, PHASE2 • Sponsor: Omar Nadeem, MD • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC